Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks

(1) Background: With the rise of multi-/pan-drug resistant (MDR/PDR) pathogens, the less utilized antibiotic Colistin has made a comeback. Colistin fell out of favor due to its small therapeutic range and high potential for toxicity. Today, it is used again as a last resort substance in treating MDR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Microorganisms
Main Authors: Ehrentraut, Stefan Felix, Muenster, Stefan, Kreyer, Stefan, Theuerkauf, Nils Ulrich, Bode, Christian, Steinhagen, Folkert, Ehrentraut, Heidi, Schewe, Jens-Christian, Weber, Matthias, Putensen, Christian, Muders, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7143967/
https://ncbi.nlm.nih.gov/pubmed/32183443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms8030415
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados